Host Immune Response in Chronic Hepatitis Delta: Implications for Pathogenesis and Therapy
Pathogens · 21.08.2025 · 14 (8) · 828
DOI: 10.3390/pathogens14080828 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pathogens, online erschienen am 21.08.2025. Verfasst von Arshi Khanam und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USA. Hauptthemen laut MEDLINE: Hepatitis D, Chronic, Hepatitis Delta Virus, Host-Pathogen Interactions. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: division of clinical care and research departmental funds.
Abstract (Originalsprache)
Chronic hepatitis delta (CHD) represents the most severe form of viral hepatitis due to rapid disease progression towards liver cancer, leading to high morbidity and mortality. Hepatitis delta virus (HDV) can only infect individuals who are infected with hepatitis B. So far, there is no cure or vaccine for HDV. Existing treatment options, including pegylated interferon-α and hepatocyte entry inhibitors, offer limited efficacy. Emerging therapeutic strategies are focused on targeting various steps of the HDV life cycle or enhancing the host immune response to promote viral elimination. A defective antiviral immune response is increasingly recognized as a culprit for HDV persistence; however, the precise immunological mechanism associated with disease progression and pathogenesis has not been well defined. This review provides an update on the current understanding of host immune response in CHD, highlighting its role in both disease pathogenesis and viral clearance. A deeper understanding of these immune correlates may lead the way to novel treatment strategies, including immunotherapies targeting host immune response that can be used in combination with other antiviral therapies to achieve more effective and durable treatment outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Clinical Care and Research, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, MD 21201, USA.
- Department of Surgery, George Washington University School of Medicine and Health Sciences, Washington, DC 20037, USA.
- Department of Gastroenterology & Hepatology, Koç University School of Medicine, Istanbul 34450, Turkey.
ORCID-Profile: Arshi Khanam, Poonam Mathur, Cihan Yurdaydin, Shyam Kottilil
Förderung
- division of clinical care and research departmental funds
Zitieren
APA
Khanam, A., Ameer, A., Mathur, P., Yurdaydin, C., & Kottilil, S. (2025). Host Immune Response in Chronic Hepatitis Delta: Implications for Pathogenesis and Therapy. Pathogens, 14(8), 828. https://doi.org/10.3390/pathogens14080828
Vancouver
Khanam A, Ameer A, Mathur P, Yurdaydin C, Kottilil S. Host Immune Response in Chronic Hepatitis Delta: Implications for Pathogenesis and Therapy. Pathogens. 2025;14(8):828. doi:10.3390/pathogens14080828
BibTeX
@article{Khanam2025,
author = {Khanam, Arshi and Ameer, Abutaleb and Mathur, Poonam and Yurdaydin, Cihan and Kottilil, Shyam},
title = {Host Immune Response in Chronic Hepatitis Delta: Implications for Pathogenesis and Therapy},
journal = {Pathogens},
year = {2025},
volume = {14},
number = {8},
pages = {828},
doi = {10.3390/pathogens14080828}
}
EUVIMED